While the Phase III results confirm prior analyst sentiments, a KOL notes that GLP-1RAs could still show potential in the ...

Lilly breaking through the $1tn market cap ceiling comes as investors have increasingly turned to pharma stocks. The S&P 500 ...

An FDA officer explains the agency’s compliance requirements for importing pharmaceuticals and biologics and processes.

The industry is showing enthusiasm for novel technologies that improve safety and carry innovation potential including in ...

OSR Company Vaximm has linked with investor BCM Europe (BCME) for a potential exclusive worldwide licence for Vaximm’s VXM01.

AstraZeneca has announced a $2bn investment plan to expand its biomanufacturing presence in Frederick, Maryland, US.

In 2024, the FDA granted a record 63 designations to antibody drug conjugates (ADCs), nearly double the previous high of 35 ...

Advances in large-volume injectors are enabling faster, more comfortable, at-home treatment. Patient-centric design, ...

Roche has received conditional marketing authorisation from the European Commission (EC) for Lunsumio (mosunetuzumab) ...

Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by Texas Attorney General Ken Paxton that they ...

Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...

Galapagos CEO Henry Gosebruch says the recent uptick in M&A activity is a positive development for the biotech as it pursues ...